Author
JoAnn V. Pinkerton
Recent research
- Health & MedicineOpen access
Elinzanetant for menopause-associated vasomotor symptoms: pooled analysis of two phase III trials
Objective This study aimed to evaluate the vasomotor symptoms (VMS) efficacy profile of elinzanetant (dual neurokinin-1 and neurokinin-3 receptor antagonist).Method Data were pooled from the phase III 26-week (12-week placebo-controlled) OASIS-1 and OASIS-2 trials, enrolling natu...